Okaltus (Dextromethorphan Hydrobromide, Guaifenesin)

Dextromethorphan Hydrobromide, the active ingredient in Okaltus, is a cough suppressant presented as a tablet for oral use. It relieves non‑productive cough and, in combination with guaifenesin, helps clear mucus in the respiratory tract of adults and children. GNH USA supplies Okaltus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Okaltus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Okaltus combines dextromethorphan and guaifenesin to address cough and mucus clearance in the respiratory system.

- Cough associated with the common cold: reduces the urge to cough and improves comfort. - Acute bronchitis: helps control coughing episodes and facilitates expectoration. - Upper respiratory tract infections: eases cough and aids mucus clearance. - Chronic obstructive pulmonary disease (COPD) exacerbations: supports symptomatic relief of cough when used as part of a broader treatment plan.

Okaltus may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: mild sedation. - Nausea: occasional upset stomach. - Dizziness: light‑headed feeling. - Dry mouth: reduced salivation. - Upper respiratory tract irritation: mild throat discomfort.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hallucinations or altered perception: rare central nervous system effects. - Severe dizziness or loss of coordination. - Persistent vomiting. - Cardiac arrhythmias in susceptible individuals.

When using Okaltus, consider the following safety measures:

- Avoid alcohol: increases risk of sedation and respiratory depression. - Do not operate machinery: potential drowsiness may impair coordination. - Monitor in patients with liver disease: hepatic metabolism may be altered. - Use caution in asthma or COPD patients: may affect airway reactivity. - Store at below 25°C: keep in the original pack, protect from moisture.

Okaltus can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Mono‑Mono‑Mono  :                                                                                                                                                                                                                                                       ... (truncated)